Biogen (BIIB) Other Operating Expenses (2009 - 2026)

Biogen has reported Other Operating Expenses for 18 years, with the latest figure at -$18.5 million in Q2 2026.

• On a quarterly basis, Other Operating Expenses rose 62.01% year-over-year to -$18.5 million in Q2 2026; TTM through Jun 2026 was $45.3 million, a 69.88% decrease from a year earlier, with the FY2025 full-year figure at -$33.6 million, down 137.92% from the prior year.
• Other Operating Expenses was -$18.5 million for Q2 2026 at Biogen, up from -$19.7 million in the prior quarter.
• The five-year high for Other Operating Expenses was $503.7 million in Q3 2022, with the low at -$300.0 million in Q3 2023.
• Average Other Operating Expenses over 5 years is $38.6 million, with a median of -$19.1 million recorded in 2026.
• The largest YoY upside for Other Operating Expenses was 344.61% in 2022 against a maximum downside of 878.99% in 2022.
• Over 5 years, Other Operating Expenses stood at -$165.3 million in 2022, then jumped by 250.15% to $248.2 million in 2023, then climbed by 13.74% to $282.3 million in 2024, then tumbled by 58.34% to $117.6 million in 2025, then slumped by 115.73% to -$18.5 million in 2026.
• The last three Other Operating Expenses figures came in at -$18.5 million (Q2 2026), -$19.7 million (Q1 2026), and $117.6 million (Q4 2025), per Business Quant data.